US FDA approves Pfizer's bleeding disorder drug for children
- Posted on June 8, 2026
- By Bing News
- 0 Views
- 1 min read
US FDA approves Pfizer's bleeding disorder drug for children
June 8 (Reuters) - The U.S. Food and Drug Administration has approved Pfizer's drug to prevent or reduce the frequency of bleeding episodes in children and in certain patients with hemophilia, the company said on Monday. The nod makes Pfizer's Hympavzi the first non-factor therapy available for pediatric patients aged 6 to 11 years with or without inhibitors. The regulator also expanded the use
